Skip to main content

Table 5 Medication classes involved in occurrence of incidents

From: A cross-sectional study: medication safety among cancer in-patients in tertiary care hospitals in KPK, Pakistan

Medication classes Site 1 (CPOE) Site 2 (HWP) Total
N % N % N %
Analgesics and antipyretics (NSAIDs*a + Opiates) 67 11.4 55 9.1 122 20.5
Antacids 31 5.3 42 6.9 73 12.2
Antibiotics or antibacterial agents 259 44 77 12.7 336 56.7
Anticonvulsants 1 0.2 1 0.2 2 0.4
Antidepressants + Tranquilizers 4 0.7 1 0.2 5 0.9
Anti-diabetic agents (Insulin and sulfonylureas) 10 1.7 4 0.7 14 2.4
Anti-diarrheal agents 2 0.3 2 0.3
Antiemetic 44 7.5 96 15.8 140 23.3
Anti-flatulent 2 0.3 2 0.3
Antihistamines 23 3.9 13 2.1 36 6
Antineoplastic agents 17 2.9 57 9.4 74 12.3
Antiprotozoal + Anti-leprosy agents 14 2.4 4 0.7 18 3.1
Antiviral 3 0.5 3 0.5
Appetite stimulants 5 0.8 5 0.8
Benzodiazepine antagonists 4 0.7 4 0.7
Bisphosphonates 8 1.3 8 1.3
Blood derivatives 2 0.3 2 0.3
Bronchodilators + Immunosuppressive agents + Mast cell stabilizers + Xanthine oxidase inhibitors 1 0.2 1 0.2
Cardiac drug + ACEIs*b + Calcium antagonists + Cardiac glycosides 4 0.7 4 0.7
Cathartics/Laxatives 13 2.2 13 2.1 26 4.3
CNS depressants + Sedatives, hypnotics and Anxiolytics (Barbiturates and Benzodiazepines) 10 1.7 24 4 34 5.7
Coagulants and Anticoagulants 19 3.2 8 1.3 27 4.5
Colony stimulating factor (CSF) 9 1.5 5 0.8 14 2.3
Cyto-protectants (Mesna) 6 1 6 1
Devices 2 0.3 2 0.3
Dietary supplements and Vitamins 7 1.2 72 11.9 79 13.1
Diuretics 11 1.8 11 1.8
Enzymes 1 0.2 1 0.2
Expectorants 5 0.8 5 0.8
Human albumin 7 1.2 7 1.2
Immunomodulatory agents 3 0.5 3 0.5
Monoclonal antibodies 5 0.9 5 0.9
Mouth washes and gargles 12 2 12 2
Ointments/Solutions/Suspensions ophthalmic + Otic/Ophthalmic/Nasal preparations 7 1.2 4 0.7 11 1.9
Opiates 1 0.2 1 0.2
Para-sympatholytic agents 4 0.7 4 0.7
Quinolones 3 0.5 3 0.5
Replacement solutions/ORS*c/Minerals/Elements/Electrolytes 16 2.7 24 4 40 6.7
Skeletal muscle relaxants 4 0.7 4 0.7
Steroids 4 0.7 11 1.8 15 2.5
Sugar/Salt substitutes 2 0.3 14 2.3 16 2.6
Sympathomimetic agents 7 1.2 2 0.3 9 1.5
Thrombolytic agents 4 0.7 4 0.7
Uricosuric agents 3 0.5 3 0.5
Total 589 100 606 100 1195  
  1. a NSAIDs Non-steroidal anti-inflammatory drugs, b ACEIs Angiotensin converting enzyme inhibitors and c ORS Oral rehydrating salts
\